Nov 7 (Reuters) - Allena Pharmaceuticals Inc ALNA.O :
* ALLENA PHARMACEUTICALS REPORTS THIRD QUARTER 2018
FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* Q3 LOSS PER SHARE $0.46
* Q3 EARNINGS PER SHARE VIEW $-0.47 -- THOMSON REUTERS
I/B/E/S
* AS OF SEPTEMBER 30, 2018, CASH AND CASH EQUIVALENTS WERE
$70.6
MILLION
* EXPECTS EXISTING CASH AND CASH EQUIVALENTS WILL BE
SUFFICIENT TO
FUND OPERATING EXPENSES, CAPITAL REQUIREMENTS INTO 2020
Source text for Eikon: ID:nGNX8xcrh3
Further company coverage: ALNA.O
((Briefs@thomsonreuters.com;))